High dietary methionine plus cholesterol stimulates early atherosclerosis and late fibrous cap development which is associated with a decrease in GRP78 positive plaque cells

International Journal of Experimental Pathology

Volumn 90, Issue 3, 2009, Pages 311-320

  Zulli, Anthony ^a,b   Hare, David L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

Cholesterol; Fibrous cap; Grp78; Methionine; Rabbit; Stable plaque

Indexed keywords

CHOLESTEROL; GLUCOSE REGULATED PROTEIN 78; METHIONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; CORONARY ARTERY DISEASE; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HEAT-SHOCK PROTEINS; MALE; METHIONINE; ORGAN CULTURE TECHNIQUES; RABBITS;

EID: 65549143134     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00649.x     Document Type: Article

References (54)

1. Aridor M. Balch W.E. (1999) Integration of endoplasmic reticulum signaling in health and disease. Nat. Med. 5, 745 751. (Pubitemid 29318607)
2. Balkan J., Oztezcan S., Hatipoglu A., Cevikbas U., Aykac-Toker G., Uysal M. (2004) Effect of a taurine treatment on the regression of existing atherosclerotic lesions in rabbits fed on a high-cholesterol diet. Biosci. Biotechnol. Biochem. 68, 1035 1039. (Pubitemid 39251416)
3. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049 1057.
4. Boyce M., Bryant K.F., Jousse C. et al. (2005) A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935 939. (Pubitemid 40229232)
5. Brattstrom L. Wilcken D.E. (2000) Homocysteine and cardiovascular disease: cause or effect? Am. J. Clin. Nutr. 72, 315 323. (Pubitemid 30620632)
6. Choi S.W., Ryu O.H., Choi S.J., Song I.S., Bleyer A.J., Hart T.C. (2005) Mutant tamm-horsfall glycoprotein accumulation in endoplasmic reticulum induces apoptosis reversed by colchicine and sodium 4-phenylbutyrate. J. Am. Soc. Nephrol. 16, 3006 3014.
7. Clarkson T.B. (1971) Animal models for atherosclerosis. A review. N. C. Med. J. 32, 88 98.
8. Cnop M., Ladriere L., Hekerman P. et al. (2007) Selective inhibition of eukaryotic translation initiation factor 2[alpha] dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J. Biol. Chem. 282, 3989 3997. (Pubitemid 47084497)
9. Constantinides P., Booth J., Carlson G. (1960) Production of advanced cholesterol atherosclerosis in the rabbit. Arch. Pathol. 70, 712 724.
10. Devries-Seimon T., Li Y., Yao P.M. et al. (2005) Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171, 61 73. (Pubitemid 41434602)
11. Di Minno G., Coppola A., Mancini F.P., Margaglione M. (1999) Homocysteine, platelet function and thrombosis. Haematologica 84 (Suppl EHA-4 61 63.
12. Duke L.M., Evans R.G., Widdop R.E. (2005) AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats. Am. J. Physiol. 288, H2289 H2297. (Pubitemid 40604117)
13. Feng B., Yao P.M., Li Y. et al. (2003) The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5, 781 792. (Pubitemid 37087166)
14. Fennessy P.A., Campbell J.H., Campbell G.R. (1994) An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit. Clin. Sci. (Lond.) 87, 685 691. (Pubitemid 24373999)
15. Flynn G.C., Pohl J., Flocco M.T., Rothman J.E. (1991) Peptide-binding specificity of the molecular chaperone BiP. Nature 353, 726 730. (Pubitemid 21912602)
16. Getz G.S. Reardon C.A. (2006) Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 242 249. (Pubitemid 43732181)
17. Ha Y.C. Barter P.J. (1982) Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp. Biochem. Physiol. B 71, 265 269.
18. Hendershot L.M. (2004) The ER function BiP is a master regulator of ER function. Mt. Sinai J. Med. 71, 289 297. (Pubitemid 39440150)
19. Iwai M., Chen R., Li Z. et al. (2005) Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112, 1636 1643. (Pubitemid 41324526)
20. Jeanpierre E., Le Tourneau T., Zawadzki C. et al. (2008) Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits. Cardiovasc. Pathol. Apr 22. [Epub ahead of print].
21. Kaul S., Zadeh A.A., Shah P.K. (2006) Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J. Am. Coll. Cardiol. 48, 914 923. (Pubitemid 44292448)
22. Kee P., Caiazza D., Rye K.A., Barrett P.H., Morehouse L.A., Barter P.J. (2006) Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits. Arterioscler. Thromb. Vasc. Biol. 26, 884 890. (Pubitemid 43732167)
23. Keech A., Simes R.J., Barter P. et al. (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366, 1849 1861. (Pubitemid 41690113)
24. Kitamuro T., Takahashi K., Ogawa K. et al. (2003) Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J. Biol. Chem. 278, 9125 9133. (Pubitemid 36800393)
25. Lefkowitch J.H. (2006) Special stains in diagnostic liver pathology. Semin. Diagn. Pathol. 23, 190 198. (Pubitemid 46176514)
26. Lentz S.R. (2005) Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 3, 1646 1654. (Pubitemid 41716550)
27. Majors A., Ehrhart L.A., Pezacka E.H. (1997) Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17, 2074 2081. (Pubitemid 28057110)
28. McCully K.S. (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. am. J. Pathol. 56, 111 128.
29. Ni M. Lee A.S. (2007) ER chaperones in mammalian development and human diseases. FEBS Lett. 581, 3641 3651. (Pubitemid 47082516)
30. Ohara Y., Peterson T.E., Sayegh H.S., Subramanian R.R., Wilcox J.N., Harrison D.G. (1995) Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 92, 898 903.
31. Outinen P.A., Sood S.K., Pfeifer S.I. et al. (1999) Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 94, 959 967. (Pubitemid 29361827)
32. Ozcan U., Yilmaz E., Ozcan L. et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137 1140. (Pubitemid 44300242)
33. Parfett C.L., Brudzynski K., Stiller C. (1990) Enhanced accumulation of mRNA for 78-kilodalton glucose-regulated protein (GRP78) in tissues of nonobese diabetic mice. Biochem. Cell Biol. 68, 1428 1432.
34. Prior J.T., Kurtz D.M., Ziegler D.D. (1961) The hypercholesteremic rabbit. An aid to understanding arteriosclerosis in man? Arch. Pathol. 71, 672 684.
35. Ramalho R.M., Borralho P.M., Castro R.E., Sola S., Steer C.J., Rodrigues C.M. (2006) Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells. J. Neurochem. 98, 1610 1618. (Pubitemid 44200450)
36. Refsum H., Ueland P.M., Nygard O., Vollset S.E. (1998) Homocysteine and cardiovascular disease. Annu. Rev. Med. 49, 31 62. (Pubitemid 28197439)
37. Schroder M. Kaufman R.J. (2005) The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739 789. (Pubitemid 40995523)
38. Seimon T. Tabas I. (2008) Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. Oct 25. [Epub ahead of print].
39. Sen U., Moshal K.S., Tyagi N., Kartha G.K., Tyagi S.C. (2006) Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells. J. Cell. Physiol. 209, 767 774. (Pubitemid 44665699)
40. Shiomi M., Ito T., Hirouchi Y., Enomoto M. (2001) Stability of atheromatous plaque affected by lesional composition: study of WHHL rabbits treated with statins. Ann. NY Acad. Sci. 947, 419 423. (Pubitemid 34059950)
41. Stary H.C. (2000) Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler. Thromb. Vasc. Biol. 20, 1177 1178. (Pubitemid 30262913)
42. Stary H.C., Chandler A.B., Glagov S. et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. 14, 840 856. (Pubitemid 24141376)
43. Stary H.C., Chandler A.B., Dinsmore R.E. et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355 1374.
44. Taha S., Azzi A., Ozer N.K. (1999) Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by a hydrogen peroxide-independent mechanism. Antioxid. Redox Signal. 1, 365 369. (Pubitemid 129622806)
45. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., Selhub J. (2003) The atherogenic effect of excess methionine intake. Proc. Natl Acad. Sci. USA 100, 15089 15094. (Pubitemid 37518021)
46. Van Winkle M. Levy L. (1970) Further studies on the reversibility of serum sickness cholesterol-induced atherosclerosis. J. Exp. Med. 132, 858 867.
47. Verges B. (2006) Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD. Curr. Opin. Lipidol. 17, 653 658.
48. Waksman R., McEwan P.E., Moore T.I. et al. (2008) PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J. Am. Coll. Cardiol. 52, 1024 1032.
49. Werstuck G.H., Lentz S.R., Dayal S. et al. (2001) Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107, 1263 1273. (Pubitemid 32494543)
50. Wookey P.J., Zulli A., Buxton B.F., Hare D.L. (2008) Calcitonin receptor immunoreactivity associated with specific cell types in diseased radial and internal mammary arteries. Histopathology 52, 605 612.
51. Zulli A., Widdop R.E., Hare D.L., Buxton B.F., Black M.J. (2003) High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler. Thromb. Vasc. Biol. 23, 1358 1363. (Pubitemid 36994522)
52. Zulli A., Hare D.L., Buxton B.F., Black M.J. (2004) High dietary methionine plus cholesterol exacerbates atherosclerosis formation in the left main coronary artery of rabbits. Atherosclerosis 176, 83 89. (Pubitemid 39078648)
53. Zulli A., Buxton B.F., Black M.J., Ming Z., Cameron A., Hare D.L. (2006) The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels. J. Histochem. Cytochem. 54, 151 159. (Pubitemid 43201636)
54. Zulli A., Buxton B.F., Black M.J., Hare D.L. (2008) Embryonic stem cells markers are present within rabbit atherosclerotic plaques. Histol. Histopathol. 23, 741 746.